Pharmaceutical products *“in the form of ribonucleic acid (RNA) therapeutics* for the treatment of severe genetic diseases*, the aforementioned goods excluding Chimeric Antigen Receptor T-cell (CAR-T) therapeutics for autoimmune diseases*

'acid':8 'aforement':19 'antigen':23 'autoimmun':33 'car':29 'car-t':28 'cell':27 'chimer':22 'diseas':17,34 'exclud':21 'form':5 'genet':16 'good':20 'pharmaceut':1 'product':2 'receptor':24 'ribonucl':7 'rna':9 'sever':15 't-cell':25 'therapeut':10,31 'treatment':13

Pharmaceutical research and development *relating to ribonucleic acid (RNA) therapeutics, the aforementioned services excluding Chimeric Antigen Receptor T-cell (CAR-T) therapeutics for autoimmune diseases*

'acid':8 'aforement':12 'antigen':16 'autoimmun':26 'car':22 'car-t':21 'cell':20 'chimer':15 'develop':4 'diseas':27 'exclud':14 'pharmaceut':1 'receptor':17 'relat':5 'research':2 'ribonucl':7 'rna':9 'servic':13 't-cell':18 'therapeut':10,24

INVERNA

Owners

Goods & Services